Evidence map›Paper›PMID 32566759›Full record

ReviewNPJ precision oncology2020

Machine learning approaches to drug response prediction: challenges and recent progress.

George Adam, Ladislav Rampášek, Zhaleh Safikhani, Petr Smirnov, Benjamin Haibe-Kains, Anna Goldenberg

Abstract readReview
In one paragraph

Review in NPJ precision oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 183 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
183citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

183 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. What Is Precision Psychotherapy?The Journal of medicine and philosophy · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

123 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

George AdamPrincess Margaret Cancer Centre, University Health Network, Toronto, ON Canada.ORCID 0000-0001-9084-3703
Ladislav RampášekDepartment of Computer Science, University of Toronto, Toronto, ON Canada.ORCID 0000-0001-7527-1196
Zhaleh SafikhaniPrincess Margaret Cancer Centre, University Health Network, Toronto, ON Canada.
Petr SmirnovPrincess Margaret Cancer Centre, University Health Network, Toronto, ON Canada.ORCID 0000-0001-9395-8450
Benjamin Haibe-KainsPrincess Margaret Cancer Centre, University Health Network, Toronto, ON Canada.
Anna GoldenbergDepartment of Computer Science, University of Toronto, Toronto, ON Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is a leading cause of death worldwide. Identifying the best treatment using computational models to personalize drug response prediction holds great promise to improve patient's chances of successful recovery. Unfortunately, the computational task of predicting drug response is very challenging, partially due to the limitations of the available data and partially due to algorithmic shortcomings. The recent advances in deep learning may open a new chapter in the search for computational drug response prediction models and ultimately result in more accurate tools for therapy response. This review provides an overview of the computational challenges and advances in drug response prediction, and focuses on comparing the machine learning techniques to be of utmost practical use for clinicians and machine learning non-experts. The incorporation of new data modalities such as single-cell profiling, along with techniques that rapidly find effective drug combinations will likely be instrumental in improving cancer care.

Indexed as

Combination drug therapyHigh-throughput screeningPharmacogenetics

Identifiers

PMID32566759
PMCPMC7296033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.